Vascular Endothelial Growth Factor-A and Platelet-Derived Growth Factor-B Combination Gene Therapy Prolongs Angiogenic Effects via Recruitment of Interstitial Mononuclear Cells and Paracrine Effects Rather Than Improved Pericyte Coverage of...

The article presents a discussion concerning a study on the vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy that prolongs the effects of angiogenic via recruitment of interstitial in the United States. The advantages of combination gene therapy are discussed. It also concludes that the combination of AdVEGF-A and AdPDGF-B intramuscular delivery causes prolonged angiogenic response.